Literature DB >> 28129898

[Loss of capture by myocardial ischemia: A case report].

A Sonou1, P M Adjagba2, M Hounkponou3, L Codjo4, C Houéhanou-Sonou5, S Assani6, T Yessoufou7, J Sacca8, M Houénassi9.   

Abstract

We report the case of a patient with pacemaker who presented chest pain during exercise followed by fainting. He has a history of arterial hypertension and diabetes. The initial examination was normal; the ventricular stimulation threshold was 1.125 volts (V) and cardiac enzymes were normal. Stress test has reproduced chest pain followed by loss of pacemaker capture and asystole. Coronary angiography showed a tight stenosis of the proximal anterior interventricular artery dilated by a drug-eluting stent. The control of stress test was normal. A stent thrombosis eight days later led to an acute coronary syndrome with recurrent syncope due to the loss of ventricular capture. The ventricular pacing threshold was then 2.25V. After revascularization and stabilization of the patient's clinical status, this threshold returned to 1.125V. This clinic case has confirmed that coronary artery disease could increase pacing threshold. It also highlights the usefulness of automatic capture algorithms in coronary patients. The stress test cannot only help to detect coronary artery disease but also allows the optimization of programming the pacemaker.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Automatic capture algorithms; Capture automatique; Cardiac pacemaker; Ischémie coronarienne; Myocardial ischemia; Seuil; Stimulateur cardiaque; Threshold

Mesh:

Year:  2017        PMID: 28129898     DOI: 10.1016/j.ancard.2016.12.009

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  1 in total

1.  Cardiac Arrest due to Failed Pacemaker Capture After Peripheral Nerve Blockade With Levobupivacaine: A Case Report.

Authors:  Asuka Kitajima; Takeshi Nakatomi; Yuji Otsuka; Masamitsu Sanui; Alan Kawarai Lefor
Journal:  A A Pract       Date:  2021-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.